Trial Profile
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease [Adenosiinin ja regadenosonin vertailu sydänlihaksen verenvirtauksen PET tutkimuksessa sepelvaltimotautia sairastavilla potilailla]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2014
Price :
$35
*
At a glance
- Drugs Adenosine (Primary) ; Regadenoson (Primary)
- Indications Coronary disorders
- Focus Diagnostic use
- 04 Mar 2014 New trial record